ORMP
Oramed Pharmaceuticals Inc.
stockNASDAQ
At CloseOct 2, 2026 3:59:59 PM EDT
4.48USD0.000%(0.00)178,322
Loading…
Loading…
185.52M
Healthcare
Biotechnology
CEO
Nadav Kidron
HQ
New York, NY, USA
Previous Close
$4.48
Beta
1.04
52-Week High
$5.47 2026-08-27
52-Week Low
$2.09 2025-11-07
SMA 50
$4.63
SMA 200
$3.92
Avg. Vol 10D
156,638
Avg. Vol 30D
211,274
Avg. Vol 90D
270,298
Relative Vol
0.84
41.60M
31.59M
75.95%
1,307,745
4.14%
7.43
58%/42%
88.02%
78.79%
0.4700%
700,000
802
3,126
15,643
Nov 12, 2026 (38d)
Jan 16, 2026 · $0.250
Jan 23, 2013 · 1-for-12.0005 (reverse)
Oct 2, 2026
Oramed Pharmaceuticals CFO Avraham Gabay sells $90,200 in stock · 
Investing.com
Sep 17, 2026
ORMP Profile
oramed pharmaceuticals (nasdaqcm:ormp) is developing proprietary technology for the oral delivery of drugs presently administered by way of injection. through its patented flagship product, an orally ingestible insulin capsule currently in phase 2 trials under the usfda, the company is seeking to revolutionize the treatment of diabetes. read more: http://www.oramed.com/investors/corporate-presentation watch: https://www.youtube.com/watch?v=5qchxtdv9eg
ORMP Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 4.75 | 2026-09-28 | -6.11% | 0.839 |
| 1M | 5.01 | 2026-09-04 | -10.98% | -0.018 |
| 3M | 4.57 | 2026-07-06 | -2.41% | 0.726 |
| 6M | 3.44 | 2026-04-06 | +29.65% | 0.667 |
| 1Y | 2.44 | 2025-10-03 | +82.79% | 1.042 |
| 2Y | 2.35 | 2024-10-04 | +89.79% | — |
| 5Y | 20.28 | 2021-10-04 | -78.01% | 1.148 |
ORMP Stock Summary
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) stock price today is $4.46, and today's volume is 178,322. ORMP is down 0.446% today. The 30 day average volume is 211,274. ORMP market cap is $185.52M with 41.60M shares outstanding.